3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
7
Lymphoma, B-Cell
5
Lymphoma
5
Rhabdoid Tumor
3
Neoplasms
3
Medulloblastoma
3
Leukemia, Myeloid, Acute
3
Leukemia
3
Sarcoma, Ewing
2
Rhabdomyosarcoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pinealoma
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Neoplasms, Germ Cell and Embryonal
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Immunoblastic Lymphadenopathy
2
Hodgkin Disease
2
Ganglioneuroblastoma
2
Ependymoma
2
Enteropathy-Associated T-Cell Lymphoma
2
Brain Neoplasms
2
Solid Tumor
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Recurrence
1
Pyloric Stenosis, Hypertrophic
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Osteosarcoma
1
Interventions
Cisplatin
7
Gemcitabine
6
pembrolizumab
4
Radiotherapy, Intensity-Modulated
4
toripalimab
2
Bevacizumab
2
tocilizumab
1
tislelizumab
1
spartalizumab
1
penpulimab
1
atezolizumab
1
Vitamin D
1
Tablets
1
Surveys and Questionnaires
1
Phantoms, Imaging
1
Oral Hygiene
1
Observation
1
Magnetic Resonance Spectroscopy
1
Immunotherapy
1
Immunohistochemistry
1
Immunoglobulin G
1
Fluorouracil
1
Disulfides
1
Dexamethasone
1
Chemoradiotherapy
1
Cetuximab
1
Carboplatin
1
Capecitabine
1
Blood Specimen Collection
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Nasopharyngeal Neoplasms
×
etoposide phosphate
×
1 year
×
Clear all
No trials found.